A Rationally Identified Panel of MicroRNAs Targets Multiple Oncogenic Pathways To Enhance Chemotherapeutic Effects in Glioblastoma Models

Researchers studied the effects of different combinations of miRNAs in glioblastoma cells by delivering synthetic miRNAs using clinically compatible PLGA-PEG nanoparticles prior to treatment with temozolomide or doxorubicin.